Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:249  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®)
Paul L. McCormack
Pediatric Drugs.2013;15(1)59
[DOI]
2Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines
Valentina Agnolon,Cristina Bruno,Bruno Galletti,Elena Mori,Mildred Ugozzoli,Carlo Pergola,Derek T. O’Hagan,Barbara C. Baudner
Vaccine.2016;34(8)1040
[DOI]
3Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines
Federico Martinón-Torres
Vaccine.2017;34(8)183
[DOI]
4Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B
Fernanda Ayane de Oliveira Santos,Nilton Lincopan,Elizabeth De Gaspari
Immunobiology.2018;223(12)750
[DOI]
5Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B
Shwu-Maan Lee,Vincent Turula,Bradford Powell,Mikkel Nissum,Mariagrazia Pizza,Claudia Magagnoli,Niranjan M. Kumar
Immunobiology.2015;223(12)187
[DOI]
6What can we learn from the microbial ecological interactions associated with polymicrobial diseases?
J.F. Antiabong,W. Boardman,A.S. Ball
Veterinary Immunology and Immunopathology.2014;158(1-2)30
[DOI]
7Booster Vaccination: The Role of Reduced Antigen Content Vaccines as a Preschool Booster
Giovanni Gabutti,Cecilia Trucchi,Michele Conversano,Giambattista Zivelonghi,Giorgio Zoppi
BioMed Research International.2014;2014(1-2)1
[DOI]
8HBV seroprevalence after 25 years of universal mass vaccination and management of non-responders to the anti-Hepatitis B vaccine: An Italian study among medical students
Francesco P. Bianchi,Maria S. Gallone,Maria F. Gallone,Angela M. V. Larocca,Luigi Vimercati,Michele Quarto,Silvio Tafuri
Journal of Viral Hepatitis.2019;26(1)136
[DOI]
9New perspectives for hexavalent vaccines
Pablo Obando-Pacheco,Irene Rivero-Calle,José Gómez-Rial,Carmen Rodríguez-Tenreiro Sánchez,Federico Martinón-Torres
Vaccine.2018;36(36)5485
[DOI]
10Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
Yanping Li,Rong Cheng Li,Qiang Ye,Changgui Li,You Ping Liu,Xiao Ma,Yanan Li,Hong Zhao,Xiaoling Chen,Deepak Assudani,Naveen Karkada,Htay Htay Han,Olivier Van Der Meeren,Narcisa Mesaros
Human Vaccines & Immunotherapeutics.2017;13(3)588
[DOI]
11Versatile and on-demand biologics co-production in yeast
Jicong Cao,Pablo Perez-Pinera,Ky Lowenhaupt,Ming-Ru Wu,Oliver Purcell,Cesar de la Fuente-Nunez,Timothy K. Lu
Nature Communications.2018;9(1)588
[DOI]
12DTaP-IPV-Hep B-Hib vaccine (Hexyon®/Hexacima®): a guide to its use in the primary and booster vaccination of infants and toddlers in Europe
Katherine A. Lyseng-Williamson,Paul L. McCormack
Drugs & Therapy Perspectives.2013;29(11)329
[DOI]
13Vaxelis® (DTaP5-HB-IPV-Hib vaccine) as primary and booster vaccination in infants and toddlers: a profile of its use
Gillian M. Keating,Katherine A. Lyseng-Williamson,Yahiya Y. Syed
Drugs & Therapy Perspectives.2017;33(5)208
[DOI]
14Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model
Priyadarshini Mukherjee,Vivek Mondal,Ushasi Bhaumik,Ritam Sinha,Sounak Sarkar,Soma Mitra,Debaki Ranjan Howlader,Suhrid Maiti,Asish Kumar Mukhopadhyay,Shanta Dutta,Hemanta Koley
Microbes and Infection.2019;33(5)208
[DOI]
15DTaP5-HB-IPV-Hib Vaccine (Vaxelis®): A Review of its Use in Primary and Booster Vaccination
Yahiya Y. Syed
Pediatric Drugs.2017;19(1)69
[DOI]
16Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
Ki Hwan Kim,Chun Soo Kim,Hwang Min Kim,Jong-Duck Kim,Sang Hyuk Ma,Dong Ho Kim,Pyoung-Han Hwang,Ji-Whan Han,Taek-Jin Lee,Joon Hyung Kim,Naveen Karkada,Narcisa Mesaros,Woo-Yun Sohn,Jong-Hyun Kim
Human Vaccines & Immunotherapeutics.2019;15(2)317
[DOI]
17Combination vaccines against diarrheal diseases
Malabi M. Venkatesan,Lillian L. Van de Verg
Human Vaccines & Immunotherapeutics.2015;15(2)00
[DOI]
18Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT-Hc in mice
Yilong Yang,Rui Yu,Xiuxu Yang,Shuling Liu,Ting Fang,Xiaohong Song,Lihua Hou,Changming Yu,Junjie Xu,Ling Fu,Shaoqiong Yi,Wei Chen
Molecular Medicine Reports.2017;15(4)2369
[DOI]
19Stability of Vaccines
N. Dumpa,K. Goel,Yuhan Guo,H. McFall,Amit Raviraj Pillai,Ashay Shukla,M. A. Repka,S. Narasimha Murthy
AAPS PharmSciTech.2019;20(2)2369
[DOI]
20Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle,Istvan Toth
ChemMedChem.2013;8(3)360
[DOI]
21Challenges for the pharmaceutical technical development of protein coformulations
Claudia Mueller,Ulrike Altenburger,Silke Mohl
Journal of Pharmacy and Pharmacology.2018;70(5)666
[DOI]
22Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection
Kai Schulze,Thomas Ebensen,Saranya Chandrudu,Mariusz Skwarczynski,Istvan Toth,Colleen Olive,Carlos A. Guzman
Nanomedicine: Nanotechnology, Biology and Medicine.2017;13(8)2463
[DOI]
23Polyvalent vaccines: High-maintenance heroes
Barbara Schlingmann,Katelyn R. Castiglia,Christopher C. Stobart,Martin L. Moore,Katherine R. Spindler
PLOS Pathogens.2018;14(4)e1006904
[DOI]
24A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity
Jonathan W. Lockner,Jenny M. Lively,Karen C. Collins,Janaína C. M. Vendruscolo,Marc R. Azar,Kim D. Janda
Journal of Medicinal Chemistry.2015;58(2)1005
[DOI]
25Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid
Henry H. Bernstein,Elisabeth R. Seyferth
Vaccine.2017;35(48)6707
[DOI]
26Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States
Nicola P. Klein,Remon Abu-Elyazeed,Brigitte Cheuvart,Winnie Janssens,Narcisa Mesaros
Human Vaccines & Immunotherapeutics.2019;15(4)809
[DOI]
27Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
So Jung An,Joo Sung Woo,Myung Hwa Chae,Sudeep Kothari,Rodney Carbis
Vaccine.2015;33(13)1614
[DOI]
28Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
Karen C. Collins,Kim D. Janda
Vaccine.2016;33(13)327
[DOI]
29Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine
Michael P. Veve,Vasilios Athans
Vaccine.2018;40(13)383
[DOI]
30Combined vaccines for prophylaxis of infectious conditions
Pravin Shende,Mansi Waghchaure
Artificial Cells, Nanomedicine, and Biotechnology.2019;47(1)696
[DOI]
31Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
Timo Vesikari,Luis Rivera,Tiina Korhonen,Anitta Ahonen,Brigitte Cheuvart,Marjan Hezareh,Winnie Janssens,Narcisa Mesaros
Human Vaccines & Immunotherapeutics.2017;13(7)1505
[DOI]
32Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer
Jan Dolhain,Winnie Janssens,Narcisa Mesaros,Linda Hanssens,Frederik Fierens
Expert Review of Vaccines.2018;17(6)513
[DOI]
33A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants
Lalitendu Mohanty,Sunil Sharma,Beauty Behera,Sachin Panwar,Charu Paliwal,Anu Gupta,Deepak Chandra Chilkoti,Anit Singh
Vaccine.2018;36(17)2378
[DOI]
34Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati,Maxim Shevtsov,Avinash Sonawane
Frontiers in Immunology.2018;9(17)2378
[DOI]
35Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization
Karl D. Brune,Can M. Buldun,Yuanyuan Li,Iona J. Taylor,Florian Brod,Sumi Biswas,Mark Howarth
Bioconjugate Chemistry.2017;28(5)1544
[DOI]
36Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
Almudena Sánchez-Matamoros,Agustí Camprodon,Jaime Maldonado,Rafael Pedrazuela,Joel Miranda
Porcine Health Management.2019;5(1)1544
[DOI]
  Addresses 
  My Preferences 


JGID
JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008